Sales starting in Japan - good news and more good news.
So it appears that sales are starting up in Japan as the company stated:
Receipt of Rare Disease Drug Designation for lomitapide from Taiwan's Ministry of Health and Welfare which allows sales in Taiwan under a named patient program.
So about 10 Japanese patients in the study in the first quarter, then widening based on success.
UK & Germany sales are starting up now too.
It also looks like they will start the pediatric study as well.